Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Security

Regencell Bioscience Holdings Limited Ordinary Shares · RGC

RGCNASDAQCommon stockCurrentCIK 1829667Updated Nov 18, 2026

Company: Regencell Bioscience Holdings Ltd →

RGC price & chart

Provider market data

Loading TradingView…

NASDAQ:RGC on TradingView ↗

TradingView · Data may be delayed

About the company

We are an early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. Our goal is to save and improve the lives of the patients, their families and caregivers and become a market leader for natural and holistic treatments for neurological disorders globally.

6-K · 2026-05-22 · 0001213900-26-060337

Company description from the cited filing.

In the news

Seeking Alpha
SEC disclosures

Recent filings

  1. 4 filing

    4 · 2026-11-17 · 0001213900-26-121409

  2. 144 filing

    144 · 2026-11-17 · 0001213900-26-121152

  3. S-8 filing

    S-8 · 2026-11-16 · 0001213900-26-120668

  4. 20-F filing

    20-F · 2026-10-07 · 0001213900-26-107581

  5. 4 filing

    4 · 2026-05-29 · 0001213900-26-062409

Show 5 more recent filings
  1. 6-K filing

    6-K · 2026-05-22 · 0001213900-26-060337

  2. 424B5 filing

    424B5 · 2026-05-19 · 0001213900-26-059114

  3. 6-K filing

    6-K · 2026-05-19 · 0001213900-26-059056

  4. 6-K filing

    6-K · 2026-05-19 · 0001213900-26-058749

  5. 6-K filing

    6-K · 2026-05-08 · 0001213900-26-053892

Financials

FY 2026 · USD
Revenue— · FY 2026
Net income-11,701,941USD · FY 2026
Source

20-F · 2026-10-07 · 0001213900-26-107581

2025-07-01 to 2026-06-30

Cash— · FY 2026
Operating income-11,724,461USD · FY 2026
Source

20-F · 2026-10-07 · 0001213900-26-107581

2025-07-01 to 2026-06-30

Diluted EPS-2.37USD per share · FY 2026
Source

20-F · 2026-10-07 · 0001213900-26-107581

2025-07-01 to 2026-06-30

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemFY 2026FY 2025FY 2024FY 2023
ASSETS
AssetsUSD14,729,559
Source

20-F · 2026-10-07 · 0001213900-26-107581

As of 2026-06-30

5,755,582
Source

20-F · 2025-10-31 · 0001213900-25-104686

As of 2025-06-30

8,438,211
Source

20-F · 2024-10-25 · 0001213900-24-090791

As of 2024-06-30

12,621,755
Source

20-F · 2023-10-27 · 0001013762-23-007289

As of 2023-06-30

Property, Plant and Equipment, NetUSD135,112
Source

20-F · 2026-10-07 · 0001213900-26-107581

As of 2026-06-30

215,434
Source

20-F · 2025-10-31 · 0001213900-25-104686

As of 2025-06-30

141,734
Source

20-F · 2024-10-25 · 0001213900-24-090791

As of 2024-06-30

440,829
Source

20-F · 2023-10-27 · 0001013762-23-007289

As of 2023-06-30

Current assets:
Assets, CurrentUSD14,223,157
Source

20-F · 2026-10-07 · 0001213900-26-107581

As of 2026-06-30

4,902,813
Source

20-F · 2025-10-31 · 0001213900-25-104686

As of 2025-06-30

8,114,013
Source

20-F · 2024-10-25 · 0001213900-24-090791

As of 2024-06-30

11,621,343
Source

20-F · 2023-10-27 · 0001013762-23-007289

As of 2023-06-30

Operating Lease, Right-of-Use AssetUSD295,620
Source

20-F · 2026-10-07 · 0001213900-26-107581

As of 2026-06-30

544,385
Source

20-F · 2025-10-31 · 0001213900-25-104686

As of 2025-06-30

84,780
Source

20-F · 2024-10-25 · 0001213900-24-090791

As of 2024-06-30

451,084
Source

20-F · 2023-10-27 · 0001013762-23-007289

As of 2023-06-30

LIABILITIES AND EQUITY
LiabilitiesUSD1,380,194
Source

20-F · 2026-10-07 · 0001213900-26-107581

As of 2026-06-30

895,308
Source

20-F · 2025-10-31 · 0001213900-25-104686

As of 2025-06-30

219,512
Source

20-F · 2024-10-25 · 0001213900-24-090791

As of 2024-06-30

632,320
Source

20-F · 2023-10-27 · 0001013762-23-007289

As of 2023-06-30

Stockholders’ equity:
Common Stock, Value, IssuedUSD4,959
Source

20-F · 2026-10-07 · 0001213900-26-107581

As of 2026-06-30

4,945
Source

20-F · 2025-10-31 · 0001213900-25-104686

As of 2025-06-30

130
Source

20-F · 2024-10-25 · 0001213900-24-090791

As of 2024-06-30

130
Source

20-F · 2023-10-27 · 0001013762-23-007289

As of 2023-06-30

Retained Earnings (Accumulated Deficit)USD-36,903,057
Source

20-F · 2026-10-07 · 0001213900-26-107581

As of 2026-06-30

-25,201,116
Source

20-F · 2025-10-31 · 0001213900-25-104686

As of 2025-06-30

-21,616,903
Source

20-F · 2024-10-25 · 0001213900-24-090791

As of 2024-06-30

-17,315,066
Source

20-F · 2023-10-27 · 0001013762-23-007289

As of 2023-06-30

Accumulated Other Comprehensive Income (Loss), Net of TaxUSD-45,262
Source

20-F · 2026-10-07 · 0001213900-26-107581

As of 2026-06-30

-64,786
Source

20-F · 2025-10-31 · 0001213900-25-104686

As of 2025-06-30

-45,766
Source

20-F · 2024-10-25 · 0001213900-24-090791

As of 2024-06-30

-86,658
Source

20-F · 2023-10-27 · 0001013762-23-007289

As of 2023-06-30

Stockholders' Equity Attributable to ParentUSD13,349,365
Source

20-F · 2026-10-07 · 0001213900-26-107581

As of 2026-06-30

4,860,274
Source

20-F · 2025-10-31 · 0001213900-25-104686

As of 2025-06-30

8,218,699
Source

20-F · 2024-10-25 · 0001213900-24-090791

As of 2024-06-30

12,030,333
Source

20-F · 2023-10-27 · 0001013762-23-007289

As of 2023-06-30

Additional Paid in Capital, Common StockUSD50,292,725
Source

20-F · 2026-10-07 · 0001213900-26-107581

As of 2026-06-30

30,121,231
Source

20-F · 2025-10-31 · 0001213900-25-104686

As of 2025-06-30

29,881,238
Source

20-F · 2024-10-25 · 0001213900-24-090791

As of 2024-06-30

29,431,927
Source

20-F · 2023-10-27 · 0001013762-23-007289

As of 2023-06-30

Liabilities and EquityUSD14,729,559
Source

20-F · 2026-10-07 · 0001213900-26-107581

As of 2026-06-30

5,755,582
Source

20-F · 2025-10-31 · 0001213900-25-104686

As of 2025-06-30

8,438,211
Source

20-F · 2024-10-25 · 0001213900-24-090791

As of 2024-06-30

12,621,755
Source

20-F · 2023-10-27 · 0001013762-23-007289

As of 2023-06-30

Current liabilities:
Liabilities, CurrentUSD1,320,695
Source

20-F · 2026-10-07 · 0001213900-26-107581

As of 2026-06-30

663,673
Source

20-F · 2025-10-31 · 0001213900-25-104686

As of 2025-06-30

193,578
Source

20-F · 2024-10-25 · 0001213900-24-090791

As of 2024-06-30

606,914
Source

20-F · 2023-10-27 · 0001013762-23-007289

As of 2023-06-30

Operating Lease, Liability, CurrentUSD236,312
Source

20-F · 2026-10-07 · 0001213900-26-107581

As of 2026-06-30

312,780
Source

20-F · 2025-10-31 · 0001213900-25-104686

As of 2025-06-30

59,807
Source

20-F · 2024-10-25 · 0001213900-24-090791

As of 2024-06-30

438,263
Source

20-F · 2023-10-27 · 0001013762-23-007289

As of 2023-06-30

Operating Lease, Liability, NoncurrentUSD59,499
Source

20-F · 2026-10-07 · 0001213900-26-107581

As of 2026-06-30

231,635
Source

20-F · 2025-10-31 · 0001213900-25-104686

As of 2025-06-30

25,934
Source

20-F · 2024-10-25 · 0001213900-24-090791

As of 2024-06-30

25,406
Source

20-F · 2023-10-27 · 0001013762-23-007289

As of 2023-06-30

Stockholders' Equity Attributable to Noncontrolling InterestUSD———-40,898
Source

20-F · 2023-10-27 · 0001013762-23-007289

As of 2023-06-30

Additional Financial Items
Accrued Liabilities, CurrentUSD1,073,596
Source

20-F · 2026-10-07 · 0001213900-26-107581

As of 2026-06-30

348,354
Source

20-F · 2025-10-31 · 0001213900-25-104686

As of 2025-06-30

125,328
Source

20-F · 2024-10-25 · 0001213900-24-090791

As of 2024-06-30

158,081
Source

20-F · 2023-10-27 · 0001013762-23-007289

As of 2023-06-30

Short-term InvestmentsUSD—2,477,900
Source

20-F · 2025-10-31 · 0001213900-25-104686

As of 2025-06-30

5,000,000
Source

20-F · 2024-10-25 · 0001213900-24-090791

As of 2024-06-30

10,000,000
Source

20-F · 2023-10-27 · 0001013762-23-007289

As of 2023-06-30

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemFY 2026FY 2025FY 2024FY 2023
Cash flows from operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD-11,701,941
Source

20-F · 2026-10-07 · 0001213900-26-107581

2025-07-01 to 2026-06-30

-3,584,213
Source

20-F · 2025-10-31 · 0001213900-25-104686

2024-07-01 to 2025-06-30

-4,363,221
Source

20-F · 2024-10-25 · 0001213900-24-090791

2023-07-01 to 2024-06-30

-6,062,329
Source

20-F · 2023-10-27 · 0001013762-23-007289

2022-07-01 to 2023-06-30

Adjustments to reconcile net income to net cash provided by operating activities:
Share-based Payment Arrangement, Noncash ExpenseUSD3,225,583
Source

20-F · 2026-10-07 · 0001213900-26-107581

2025-07-01 to 2026-06-30

244,808
Source

20-F · 2025-10-31 · 0001213900-25-104686

2024-07-01 to 2025-06-30

449,311
Source

20-F · 2024-10-25 · 0001213900-24-090791

2023-07-01 to 2024-06-30

922,623
Source

20-F · 2023-10-27 · 0001013762-23-007289

2022-07-01 to 2023-06-30

Net Cash Provided by (Used in) Operating ActivitiesUSD-7,695,530
Source

20-F · 2026-10-07 · 0001213900-26-107581

2025-07-01 to 2026-06-30

-3,113,576
Source

20-F · 2025-10-31 · 0001213900-25-104686

2024-07-01 to 2025-06-30

-4,001,687
Source

20-F · 2024-10-25 · 0001213900-24-090791

2023-07-01 to 2024-06-30

-4,962,949
Source

20-F · 2023-10-27 · 0001013762-23-007289

2022-07-01 to 2023-06-30

Cash flows from investing activities:
Net Cash Provided by (Used in) Investing ActivitiesUSD2,504,038
Source

20-F · 2026-10-07 · 0001213900-26-107581

2025-07-01 to 2026-06-30

2,686,216
Source

20-F · 2025-10-31 · 0001213900-25-104686

2024-07-01 to 2025-06-30

5,242,624
Source

20-F · 2024-10-25 · 0001213900-24-090791

2023-07-01 to 2024-06-30

58,978
Source

20-F · 2023-10-27 · 0001013762-23-007289

2022-07-01 to 2023-06-30

Payments to Acquire Property, Plant, and EquipmentUSD—152,689
Source

20-F · 2025-10-31 · 0001213900-25-104686

2024-07-01 to 2025-06-30

5,376
Source

20-F · 2024-10-25 · 0001213900-24-090791

2023-07-01 to 2024-06-30

27,392
Source

20-F · 2023-10-27 · 0001013762-23-007289

2022-07-01 to 2023-06-30

Cash flows from financing activities:
Net Cash Provided by (Used in) Financing ActivitiesUSD16,945,925
Source

20-F · 2026-10-07 · 0001213900-26-107581

2025-07-01 to 2026-06-30

—102,282
Source

20-F · 2024-10-25 · 0001213900-24-090791

2023-07-01 to 2024-06-30

134,913
Source

20-F · 2023-10-27 · 0001013762-23-007289

2022-07-01 to 2023-06-30

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD11,773,340
Source

20-F · 2026-10-07 · 0001213900-26-107581

2025-07-01 to 2026-06-30

-542,120
Source

20-F · 2025-10-31 · 0001213900-25-104686

2024-07-01 to 2025-06-30

1,396,440
Source

20-F · 2024-10-25 · 0001213900-24-090791

2023-07-01 to 2024-06-30

-4,852,203
Source

20-F · 2023-10-27 · 0001013762-23-007289

2022-07-01 to 2023-06-30

Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD14,192,455
Source

20-F · 2026-10-07 · 0001213900-26-107581

As of 2026-06-30

2,419,115
Source

20-F · 2025-10-31 · 0001213900-25-104686

As of 2025-06-30

2,961,235
Source

20-F · 2024-10-25 · 0001213900-24-090791

As of 2024-06-30

1,564,795
Source

20-F · 2023-10-27 · 0001013762-23-007289

As of 2023-06-30

Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD18,907
Source

20-F · 2026-10-07 · 0001213900-26-107581

2025-07-01 to 2026-06-30

-114,760
Source

20-F · 2025-10-31 · 0001213900-25-104686

2024-07-01 to 2025-06-30

53,221
Source

20-F · 2024-10-25 · 0001213900-24-090791

2023-07-01 to 2024-06-30

-83,145
Source

20-F · 2023-10-27 · 0001013762-23-007289

2022-07-01 to 2023-06-30

Additional Financial Items
Share-based Payment Arrangement, ExpenseUSD3,226,000
Source

20-F · 2026-10-07 · 0001213900-26-107581

2025-07-01 to 2026-06-30

245,000
Source

20-F · 2025-10-31 · 0001213900-25-104686

2024-07-01 to 2025-06-30

449,000
Source

20-F · 2024-10-25 · 0001213900-24-090791

2023-07-01 to 2024-06-30

—
DepreciationUSD80,908
Source

20-F · 2026-10-07 · 0001213900-26-107581

2025-07-01 to 2026-06-30

77,692
Source

20-F · 2025-10-31 · 0001213900-25-104686

2024-07-01 to 2025-06-30

305,780
Source

20-F · 2024-10-25 · 0001213900-24-090791

2023-07-01 to 2024-06-30

293,135
Source

20-F · 2023-10-27 · 0001013762-23-007289

2022-07-01 to 2023-06-30

Gain (Loss) on Disposition of Property Plant EquipmentUSD———-1,415
Source

20-F · 2023-10-27 · 0001013762-23-007289

2022-07-01 to 2023-06-30

General and Administrative ExpenseUSD10,418,348
Source

20-F · 2026-10-07 · 0001213900-26-107581

2025-07-01 to 2026-06-30

2,813,682
Source

20-F · 2025-10-31 · 0001213900-25-104686

2024-07-01 to 2025-06-30

3,545,066
Source

20-F · 2024-10-25 · 0001213900-24-090791

2023-07-01 to 2024-06-30

4,429,379
Source

20-F · 2023-10-27 · 0001013762-23-007289

2022-07-01 to 2023-06-30

Investment Income, InterestUSD22,520
Source

20-F · 2026-10-07 · 0001213900-26-107581

2025-07-01 to 2026-06-30

185,772
Source

20-F · 2025-10-31 · 0001213900-25-104686

2024-07-01 to 2025-06-30

248,000
Source

20-F · 2024-10-25 · 0001213900-24-090791

2023-07-01 to 2024-06-30

85,400
Source

20-F · 2023-10-27 · 0001013762-23-007289

2022-07-01 to 2023-06-30

Net Income (Loss) Attributable to ParentUSD-11,701,941
Source

20-F · 2026-10-07 · 0001213900-26-107581

2025-07-01 to 2026-06-30

-3,584,213
Source

20-F · 2025-10-31 · 0001213900-25-104686

2024-07-01 to 2025-06-30

-4,301,837
Source

20-F · 2024-10-25 · 0001213900-24-090791

2023-07-01 to 2024-06-30

-5,871,130
Source

20-F · 2023-10-27 · 0001013762-23-007289

2022-07-01 to 2023-06-30

Net Income (Loss) Attributable to Noncontrolling InterestUSD——-61,384
Source

20-F · 2024-10-25 · 0001213900-24-090791

2023-07-01 to 2024-06-30

-191,199
Source

20-F · 2023-10-27 · 0001013762-23-007289

2022-07-01 to 2023-06-30

Net Income (Loss) Available to Common Stockholders, BasicUSD———-5,957,788
Source

20-F · 2023-10-27 · 0001013762-23-007289

2022-07-01 to 2023-06-30

Operating ExpensesUSD11,724,461
Source

20-F · 2026-10-07 · 0001213900-26-107581

2025-07-01 to 2026-06-30

3,769,985
Source

20-F · 2025-10-31 · 0001213900-25-104686

2024-07-01 to 2025-06-30

4,736,726
Source

20-F · 2024-10-25 · 0001213900-24-090791

2023-07-01 to 2024-06-30

6,273,671
Source

20-F · 2023-10-27 · 0001013762-23-007289

2022-07-01 to 2023-06-30

Proceeds from Issuance of Common StockUSD18,620,000
Source

20-F · 2026-10-07 · 0001213900-26-107581

2025-07-01 to 2026-06-30

———
Proceeds from Noncontrolling InterestsUSD——102,282
Source

20-F · 2024-10-25 · 0001213900-24-090791

2023-07-01 to 2024-06-30

134,913
Source

20-F · 2023-10-27 · 0001013762-23-007289

2022-07-01 to 2023-06-30

Proceeds from Stock Options ExercisedUSD102,561
Source

20-F · 2026-10-07 · 0001213900-26-107581

2025-07-01 to 2026-06-30

———

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemFY 2026FY 2025FY 2024FY 2023
Operating Income (Loss)USD-11,724,461
Source

20-F · 2026-10-07 · 0001213900-26-107581

2025-07-01 to 2026-06-30

-3,769,985
Source

20-F · 2025-10-31 · 0001213900-25-104686

2024-07-01 to 2025-06-30

-4,736,726
Source

20-F · 2024-10-25 · 0001213900-24-090791

2023-07-01 to 2024-06-30

-6,273,671
Source

20-F · 2023-10-27 · 0001013762-23-007289

2022-07-01 to 2023-06-30

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD-11,701,941
Source

20-F · 2026-10-07 · 0001213900-26-107581

2025-07-01 to 2026-06-30

-3,584,213
Source

20-F · 2025-10-31 · 0001213900-25-104686

2024-07-01 to 2025-06-30

-4,363,221
Source

20-F · 2024-10-25 · 0001213900-24-090791

2023-07-01 to 2024-06-30

-6,062,329
Source

20-F · 2023-10-27 · 0001013762-23-007289

2022-07-01 to 2023-06-30

Net Income (Loss) Attributable to Noncontrolling InterestUSD——-61,384
Source

20-F · 2024-10-25 · 0001213900-24-090791

2023-07-01 to 2024-06-30

-191,199
Source

20-F · 2023-10-27 · 0001013762-23-007289

2022-07-01 to 2023-06-30

Net Income (Loss) Attributable to ParentUSD-11,701,941
Source

20-F · 2026-10-07 · 0001213900-26-107581

2025-07-01 to 2026-06-30

-3,584,213
Source

20-F · 2025-10-31 · 0001213900-25-104686

2024-07-01 to 2025-06-30

-4,301,837
Source

20-F · 2024-10-25 · 0001213900-24-090791

2023-07-01 to 2024-06-30

-5,871,130
Source

20-F · 2023-10-27 · 0001013762-23-007289

2022-07-01 to 2023-06-30

Earnings Per Share, BasicUSD per share-2.37
Source

20-F · 2026-10-07 · 0001213900-26-107581

2025-07-01 to 2026-06-30

-0.72
Source

20-F · 2025-10-31 · 0001213900-25-104686

2024-07-01 to 2025-06-30

-0.33
Source

20-F · 2024-10-25 · 0001213900-24-090791

2023-07-01 to 2024-06-30

0.45
Source

20-F · 2023-10-27 · 0001013762-23-007289

2022-07-01 to 2023-06-30

Earnings Per Share, DilutedUSD per share-2.37
Source

20-F · 2026-10-07 · 0001213900-26-107581

2025-07-01 to 2026-06-30

-0.72
Source

20-F · 2025-10-31 · 0001213900-25-104686

2024-07-01 to 2025-06-30

-0.33
Source

20-F · 2024-10-25 · 0001213900-24-090791

2023-07-01 to 2024-06-30

-0.45
Source

20-F · 2023-10-27 · 0001013762-23-007289

2022-07-01 to 2023-06-30

Weighted Average Number of Shares Outstanding, Basicshares494,603,400
Source

20-F · 2026-10-07 · 0001213900-26-107581

2025-07-01 to 2026-06-30

494,488,908
Source

20-F · 2025-10-31 · 0001213900-25-104686

2024-07-01 to 2025-06-30

13,012,866
Source

20-F · 2024-10-25 · 0001213900-24-090791

2023-07-01 to 2024-06-30

13,012,866
Source

20-F · 2023-10-27 · 0001013762-23-007289

2022-07-01 to 2023-06-30

Weighted Average Number of Shares Outstanding, Dilutedshares494,603,400
Source

20-F · 2026-10-07 · 0001213900-26-107581

2025-07-01 to 2026-06-30

494,488,908
Source

20-F · 2025-10-31 · 0001213900-25-104686

2024-07-01 to 2025-06-30

13,012,866
Source

20-F · 2024-10-25 · 0001213900-24-090791

2023-07-01 to 2024-06-30

13,012,866
Source

20-F · 2023-10-27 · 0001013762-23-007289

2022-07-01 to 2023-06-30

Additional Financial Items
General and Administrative ExpenseUSD10,418,348
Source

20-F · 2026-10-07 · 0001213900-26-107581

2025-07-01 to 2026-06-30

2,813,682
Source

20-F · 2025-10-31 · 0001213900-25-104686

2024-07-01 to 2025-06-30

3,545,066
Source

20-F · 2024-10-25 · 0001213900-24-090791

2023-07-01 to 2024-06-30

4,429,379
Source

20-F · 2023-10-27 · 0001013762-23-007289

2022-07-01 to 2023-06-30

Investment Income, InterestUSD22,520
Source

20-F · 2026-10-07 · 0001213900-26-107581

2025-07-01 to 2026-06-30

185,772
Source

20-F · 2025-10-31 · 0001213900-25-104686

2024-07-01 to 2025-06-30

248,000
Source

20-F · 2024-10-25 · 0001213900-24-090791

2023-07-01 to 2024-06-30

85,400
Source

20-F · 2023-10-27 · 0001013762-23-007289

2022-07-01 to 2023-06-30

Net Income (Loss) Available to Common Stockholders, BasicUSD———-5,957,788
Source

20-F · 2023-10-27 · 0001013762-23-007289

2022-07-01 to 2023-06-30

Operating ExpensesUSD11,724,461
Source

20-F · 2026-10-07 · 0001213900-26-107581

2025-07-01 to 2026-06-30

3,769,985
Source

20-F · 2025-10-31 · 0001213900-25-104686

2024-07-01 to 2025-06-30

4,736,726
Source

20-F · 2024-10-25 · 0001213900-24-090791

2023-07-01 to 2024-06-30

6,273,671
Source

20-F · 2023-10-27 · 0001013762-23-007289

2022-07-01 to 2023-06-30

Other IncomeUSD——373,505
Source

20-F · 2024-10-25 · 0001213900-24-090791

2023-07-01 to 2024-06-30

211,342
Source

20-F · 2023-10-27 · 0001013762-23-007289

2022-07-01 to 2023-06-30

Research and Development ExpenseUSD1,299,627
Source

20-F · 2026-10-07 · 0001213900-26-107581

2025-07-01 to 2026-06-30

948,289
Source

20-F · 2025-10-31 · 0001213900-25-104686

2024-07-01 to 2025-06-30

1,066,233
Source

20-F · 2024-10-25 · 0001213900-24-090791

2023-07-01 to 2024-06-30

1,581,628
Source

20-F · 2023-10-27 · 0001013762-23-007289

2022-07-01 to 2023-06-30

Selling and Marketing ExpenseUSD6,486
Source

20-F · 2026-10-07 · 0001213900-26-107581

2025-07-01 to 2026-06-30

8,014
Source

20-F · 2025-10-31 · 0001213900-25-104686

2024-07-01 to 2025-06-30

125,427
Source

20-F · 2024-10-25 · 0001213900-24-090791

2023-07-01 to 2024-06-30

262,664
Source

20-F · 2023-10-27 · 0001013762-23-007289

2022-07-01 to 2023-06-30

Lines labelled “Derived” are calculated from reported figures.

Filing attachments

ea029147301ex99-1.htm · 6-K · 2026-05-22

Exhibit 99.1 Regencell Bioscience Holdings Limited Announces Closing of Registered Direct Offering of Ordinary Shares HONG KONG, May 22, 2026 - Regencell Bioscience Holdings Limited (Nasdaq: RGC) (the “Company”) announced the closing of a registered direct offering (the “offering”) of approximately $20.0 million led by a $19 million investment from a new fundamental institutional investor with further participation from Univest Securities, LLC (“Univest”), as previously announced on May 19, 20…

6-K · 2026-05-22 · 0001213900-26-060337

Read attachment ↗
ea029147201ex99-1.htm · 6-K · 2026-05-19

Exhibit 99.1 Regencell Bioscience Holdings Limited Announces Registered Direct Offering of Ordinary Shares HONG KONG, May 19, 2026 - Regencell Bioscience Holdings Limited (Nasdaq: RGC) (the “Company”), today announced that it has entered into a definitive agreement with investors for the purchase and sale of an aggregate of 985,222 of the Company’s ordinary share, par value $0.00001 per share (the “ Ordinary Shares”) at a purchase price of $20.30 per Ordinary Share in a registered direct offer…

6-K · 2026-05-19 · 0001213900-26-058749

Read attachment ↗
ea028960501ex99-1.htm · 6-K · 2026-05-08

Exhibit 99.1 Regencell Bioscience Holdings Limited Announces First Half 2026 Management Financial Results HONG KONG, May 8, 2026 - Regencell Bioscience Holdings Limited (Nasdaq: RGC) (the “Company”) today announced its unaudited condensed consolidated interim financial results for the six months ended December 31, 2025. UNAUDITED CONDENSED CONSOLIDATED INTERIM BALANCE SHEETS As of As of …

6-K · 2026-05-08 · 0001213900-26-053892

Read attachment ↗
ea028960501ex99-2.htm · 6-K · 2026-05-08

Exhibit 99.2 REGENCELL BIOSCIENCE HOLDINGS LIMITED Index to Condensed Consolidated Financial Statements Condensed Consolidated Balance Sheets at December 31, 2025 and June 30, 2025 (Unaudited) F-2 Condensed Consolidated Statements of Operations and Comprehensive Loss for the Six Months Ended December 31, 2025 and 2024 (Unaudited) F-3 Condensed Consolidated Statements of Changes in Shareholders’ Equity for the Six Months Ended Decem…

6-K · 2026-05-08 · 0001213900-26-053892

Read attachment ↗
ea027698901ex99-1_regencell.htm · 6-K · 2026-02-13

Exhibit 99.1 FORM OF Fifth EXTENSION OF letter of Lock-Up Undertaking Date: From: (the “Optionee”) To: Regencell Bioscience Holdings Limited (the “Company”) References are made in this forth extension of the letter of lock-up undertaking (this “Fifth Extension of Lock-Up Undertaking”) to: An agreement of option to purchase ordinary shares of Regencell Bioscience Holdings Limited dated June 9, 2021, under which the Company granted certain options (the “Options”) to purchas…

6-K · 2026-02-13 · 0001213900-26-015922

Read attachment ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.